Bleichroeder’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
SL
Bleichroeder's CGEM Position: Q3 2026 in Review
Bleichroeder held its Cullinan Oncology (CGEM) position steady in Q3 2026 at 250,000 shares worth $3.84M. The position accounts for 0.38% of the portfolio, ranked #49.
Bleichroeder first reported a position in CGEM in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.55M in Q2 2026. 125 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.
- Bleichroeder held 250,000 shares of Cullinan Oncology worth $3.84M as of Q3 2026.
- Bleichroeder left its Cullinan Oncology share count unchanged in Q3 2026.
- Cullinan Oncology made up 0.38% of Bleichroeder's portfolio in Q3 2026, its #49 holding.
- Bleichroeder first reported a position in Cullinan Oncology in Q1 2026 and has held it in 3 quarters since.
- Bleichroeder's Cullinan Oncology position peaked at $4.55M in Q2 2026.
- 125 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2026.
Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.